U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07280312) titled 'Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions' on Dec. 02.
Brief Summary: This clinical trial studies how well ultrasound microvessel imaging (UMI) works in evaluating ovarian and adnexal lesions in patients who are scheduled to have surgical treatment for their ovarian or adnexal lesions as part of their clinical care. Ovarian cancer is the most lethal gynecologic malignancy, often diagnosed at an advanced stage. Current diagnostic tools include a blood test (serum cancer antigen 125 [CA125]) and transvaginal ultrasound. However, CA125 has limited diagnostic accuracy and is Food and Drug Administr...